CEO at Valisure

Founded and funded Valisure in 2015 with a team of Yale entrepreneurs. Developed a novel analytical technology for the precision analysis of pharmaceuticals which received full ISO 17025 accreditation and 3 patent filings.  Secured an unprecedented combination of FDA, DEA and state licenses and registrations to launch a truly novel and disruptive business model that combines both analytical laboratory and pharmacy. Spearheaded the rapid growth and financing of the company and put the major components in motion to launch the nation's first digital pharmacy that dispenses only chemically validated medications in 2018.


Valisure

Invest in early stage technology and novel business models with potential for disruptive impact.   An active member of the Landmark Angels group but invest independently.


Assist with the corporate management and outreach of Family ReEntry and help in their mission to empower individuals and strengthen families impacted by the criminal justice system.


Manage product commercialization and life cycle for advanced technology development programs of Ion Torrent's semiconductor sequencing platform.  Closely connect with R&D to provide insight and direction based on market and technical expertise.  Successfully completed development and commercially launched Ion's flagship technology program.
    
        …
      
        see more
      
    



Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.


      Thermo Fisher Scientific
        
  

Manage small real estate investment firm specializing in New Haven properties.  Sold business at 205% ROI.


Manage sequencing facility utilizing Ion Torrent technology with a focus on unique and broadly impacting sequencing projects.


About us

  The Rothberg Institute For Childhood Diseases is a non-profit organization dedicated to finding a cure for children suffering from Tuberous Sclerosis Complex (TSC).

The Rothberg Institute (TRI) operates a wet laboratory in Guilford CT using Ion Torrent technology; TRI also promotes development through partnerships with organizations like the TSC Alliance, Yale University, Harvard University and The Fox Chase Cancer Center.

The Rothberg Institute

Direct majority of chemistry related research at Ion Torrent and development leader for the Proton 2 system.


About us

  Life Technologies is now part of Thermo Fisher Scientific. To see what’s new, go to https://www.linkedin.com/company/thermo-fisher-scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Life Technologies

Lead R&D team to develop Ion Sphere technology for commercial launch.  Invented new manufacturing processes enabling Ion Sphere improvements to increase sequencing output a further 4X. Facilitate the expansion of bead efforts at other Life sites and the development of the Proton program.



      Ion Torrent by Life Technologies
  

Establish proof of principle for Ion Torrent Technology.  Co-inventor of "Ion Spheres" enabling 4X signal boost on Ion platform.  Spear headed Ion Sphere development and leveraged small team to invent novel manufacturing processes and analytical methods.



      Synthetic Genomics, Inc.
  


      RainDance Technologies
  

About us

  454 Life Sciences, a center of excellence of Roche Applied Science, develops and commercializes the innovative Genome Sequencer™ system for ultra-high-throughput DNA sequencing. Specific applications include de novo sequencing and re-sequencing of genomes, metagenomics, RNA analysis, and targeted sequencing of DNA regions of interest. The hallmarks of 454 Sequencing™ are its simple, unbiased sample preparation and long, highly accurate sequence reads, including paired reads. 454 Sequencing technology has enabled hundreds of peer-reviewed studies in diverse research fields such as cancer and infectious disease research, drug discovery, marine biology, anthropology, paleontology and many more.


      454 Life Sciences
  

For more than 300 years, Yale University has inspired the minds that inspire the world. Based in New Haven, Connecticut, Yale brings people and ideas together for positive impact around the globe. A research university that focuses on students and encourages learning as an essential way of life, Yale is a place for connection, creativity, and innovation among cultures and across disciplines.

CEO at Valisure

Valisure

CEO

Startups

Angel Investor

Family ReEntry

Member Board Of Directors

Thermo Fisher Scientific

Director Product Management

Pallasite Ventures

Founder & Chairman

The Rothberg Institute

Sequencing Facility Director

Life Technologies

Head of Chemistry R&D

Ion Torrent by Life Technologies

Manager, Chemistry R&D

Ion Torrent by Life Technologies

Research Associate

Synthetic Genomics, Inc.

Molecular Biology Consultant

RainDance Technologies

Chairman Advisor, Market Research & Business Development

454 Life Sciences

Sales Associate & Analyst

Yale University